[1] NormanRJ,DewaillyD,LegroRS,HickeyTE,CarminaE,RosatoF, 2007.Polycystic ovary syndrome,Lancet 6736 61345 -2
[2] 2004.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome,Fertil Steril 81 19 -25
[3] ArticleR,SyndromePO, 2018.EC Gynaecology Review Article Polycystic Ovary Syndrome and Early Pregnancy Loss: A Review Article, 2 35 -42
[4] CostelloMF,MissoML,WongJ,HartR,RombautsL,MelderA, 2012.The treatment of infertility in polycystic ovary syndrome: A brief update,Aust New Zealand J Obstet Gynaecol 52 400 -403
[5] KosovaG,UrbanekM., 2013.Genetics of the polycystic ovary syndrome,Mol Cell Endocrinol 373 29 -38
[6] VinkJM,SadrzadehS,LambalkCB,BoomsmaDI, 2006.Heritability of polycystic ovary syndrome in a Dutch twinfamily study,J Clini Endocrinol Metabol 1494 2100 -2104
[7] BalenAH,RutherfordAJ, 2007.Managing anovulatory infertility and polycystic ovary syndrome,BMJ [Internet] 10 663 -666
[8] Velija-Ašimi Z, 2013.Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment,Bosnian journal of basic medical sciences / Udruženje basičnih mediciniskih znanosti = Association of Basic Medical Sciences 13 180 -185
[9] DafopoulosK,VenetisC,MessiniCI,PournarasS,AnifandisG,GarasA, 2011.Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone,Reprod Biol Endocrinol 9 59 -
[10] MagoffinDA, 2005.Ovarian theca cell,Inter J Biochem Cell Bio 01 1344 -1349
[11] EdsonMA,NagarajaAK,MatzukMM, 2009.The mammalian ovary from genesis to revelation,Endocr Rev 0012 624 -712
[12] SirmansSM,PateKA, 2013.Epidemiology, diagnosis, and management of polycystic ovary syndrome,Clin Epidemiol 6 1 -13
[13] RosnerW,AuchusRJ,AzzizR,SlussPM,RaffH, 2007.Position statement: Utility, limitations, and pitfalls in measuring testosterone: An endocrine society position statement,J Clini Endocrinol Metabo 10 1864 -413
[14] PrapasN,KarkanakiA,PrapasI,KalogiannidisI,KatsikisI,PanidisD., 2009.Genetics of polycystic ovary syndrome,Hippokratia 13 216 -223
[15] GoodarziMO,JonesMR,LiX,ChuaAK,GarciaOA,ChenYDI, 2012.Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts,J Med Genet 49 90 -
[16] ChenZ-J,ZhaoH,HeL,ShiY,QinY,ShiY,NatGenet, 2011.Genomewide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3, 10 55 -59
[17] ShiY,ZhaoH,ShiY,CaoY,YangD,LiZ, 2012.Genomewide association study identifies eight new risk loci for polycystic ovary syndrome,Nat Genet 10 1020 -1025
[18] 18 PrapasN,KarkanakiA,PrapasI,KalogiannidisI,KatsikisI,PanidisD., 2009.Genetics of polycystic ovary syndrome,Hippokratia 13 216 -223
[19] PauC,SaxenaR,WeltCK, 2012.Evaluating reported candidate gene associations with polycystic ovary syndrome,Fertil Steril 12 1774 -1778
[20] SabatierL,MiosgeN,HubmacherD,LinG,DavisEC,ReinhardtDP, 2010.Fibrillin-3 expression in human development,Matrix Biol 10 43 -52
[21] SambrookJ,FritschEF,ManiatisT. Molecular,Cloning : A Laboratory,Manual, 1989., -
[22] SeelowD,SchuelkeM,HildebrandtF,Nürnberg P. HomozygosityMapper -, 2009.An interactive approach to homozygosity mapping,Nucleic Acids Res 10 -
[23] DumesicDA,OberfieldSE,Stener-VictorinE,MarshallJC,LavenJS,LegroRS, 2015.Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome,Endocr Rev 36 487 -525
[24] BarrettES,SobolewskiM., 2014.Polycystic ovary syndrome: Do endocrine-disrupting chemicals play a role?,Seminars Reprod Med 10 166 -176
[25] FranksS,GharaniN,WaterworthD,BattyS,WhiteD,Williamson R, 2012.Genetics of polycystic ovary syndrome,Mol Cell Endocrinol 10 123 -128
[26] PauCT,MosbrugerT,SaxenaR,WeltCK, 2017.Phenotype and tissue expression as a function of genetic risk in polycystic ovary syndrome,PLoS ONE 12 -
[27] GilissenC,Hehir-KwaJY,ThungDT,van BonBWM,WillemsenMH, 2014.Genome sequencing identifies major causes of severe intellectual disability,Nature 10 344 -347